{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:27:41Z","timestamp":1792787261001,"version":"4.5.0"},"reference-count":30,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"unspecified","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014089","name":"Boehringer Ingelheim France","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100014089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"French Society of Nephrology Dialysis and Transplantation","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"https:\/\/ror.org\/01sksqf03","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Assistance Publique des H\u00f4pitaux de Paris","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Lilly France","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Programme Hospitalier de Recherche Clinique","award":["No. 2016-1348-DRC-FI-D"],"award-info":[{"award-number":["No. 2016-1348-DRC-FI-D"]}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fresenius Medical Care","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Merck Sharp & Dohme-Chibret","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Sanofi-Genzyme","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-IA-COH-2012\/3731"],"award-info":[{"award-number":["ANR-IA-COH-2012\/3731"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Vifor France","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Baxter","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Minist\u00e8re de l\u2019Enseignement sup\u00e9rieur et de la Recherche","award":["2023-1322"],"award-info":[{"award-number":["2023-1322"]}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Ment Health"],"accepted":{"date-parts":[[2026,5,9]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Depression is closely linked to neuroinflammation, and in chronic kidney disease, the accumulation of uremic toxins (UTs) may promote neuroinflammatory processes through the activation of inflammatory pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The objective of this longitudinal study was to evaluate the association between UTs and depressive symptoms in a large, well-characterised cohort of non-dialysed adults with chronic kidney disease, a population in which this relationship had not yet been investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort comprised 3033 CKD stage 2\u20135 patients with 5 years of follow-up. Changes over time in depressive symptoms were assessed on the Center for Epidemiologic Studies Depression (CESD) scale. Mixed models were used to examine associations between the change in the CESD score and baseline levels of the UTs phenylacetylglutamine (PAG), indoxyl sulphate (IS), indole-3-acetic acid (IAA), p-cresyl sulphate, kynurenine, kynurenic acid and trimethylamine N-oxide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>2165 patients were included (median age: 68 years; mean estimated glomerular filtration rate (eGFR): 35\u2009mL\/min\/1.73\u2009m\u00b2; median baseline CESD score: 7; mean follow-up time: 4.0 years). After adjustment for confounders, the CESD score was found to have increased by 0.11 (0.04 to 0.18) points per year. A doubling in PAG level was associated with an additional increase of 0.06 (0.01 to 0.18) points per year in the CESD. A doubling in IS and IAA levels was associated with a higher mean CESD score (0.20 (0.01 to 0.39) for IS and 0.28 (0.05 to 0.50) for IAA) but not with the score\u2019s change over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PAG was significantly associated with changes in CESD score over time. Higher IS and IAA levels were linked to higher mean scores. Further studies are needed to confirm these results and to determine whether lowering serum UT levels would help to manage depressive symptoms in patients with CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical implications<\/jats:title>\n                    <jats:p>Further research is needed to clarify the role of UTs; a better understanding could uncover novel metabolic pathways and inform new therapeutic strategies to complement the management of depressive symptoms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjment-2026-302537","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:40:24Z","timestamp":1782315624000},"page":"e302537","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Depressive symptoms in chronic kidney disease: the hidden role of uremic toxins"],"prefix":"10.1136","volume":"29","clinical-trial-number":[{"clinical-trial-number":"nct03381950","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03381950","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3666-1407","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Levassort","sequence":"first","affiliation":[{"name":"Ambroise Par\u00e9 Hospital, University Medical Department 1, Geriatric Department, AP-HP, University Hospital Group Pais Saclay, Versailles Saint-Quentin University, Boulogne-Billancourt, France"},{"name":"Centre for Research in Epidemiology and Population Health (CESP), Paris-Saclay University, Inserm U1018, Versailles Saint-Quentin University, Clinical Epidemiology Team, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Liabeuf","sequence":"additional","affiliation":[{"name":"Pharmacoepidemiology Unit, Department of Clinical Pharmacology, Amiens-Picardie University Medical Center, Amiens, Hauts-de-France, France"},{"name":"MP3CV Laboratory, Jules Verne University of Picardie, Amiens, Hauts-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Boucquemont","sequence":"additional","affiliation":[{"name":"Centre for Research in Epidemiology and Population Health (CESP), Paris-Saclay University, Inserm U1018, Versailles Saint-Quentin University, Clinical Epidemiology Team, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0837-634X","authenticated-orcid":false,"given":"Gaye","family":"Hafez","sequence":"additional","affiliation":[{"name":"Centre for Research in Epidemiology and Population Health (CESP), Paris-Saclay University, Inserm U1018, Versailles Saint-Quentin University, Clinical Epidemiology Team, Villejuif, France"},{"name":"Department of Pharmacology, Faculty of Pharmacy, Altinbas University, Istanbul, \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solene M","family":"Laville","sequence":"additional","affiliation":[{"name":"Pharmacoepidemiology Unit, Department of Clinical Pharmacology, Amiens-Picardie University Medical Center, Amiens, Hauts-de-France, France"},{"name":"MP3CV Laboratory, Jules Verne University of Picardie, Amiens, Hauts-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Lange","sequence":"additional","affiliation":[{"name":"Centre for Research in Epidemiology and Population Health (CESP), Paris-Saclay University, Inserm U1018, Versailles Saint-Quentin University, Clinical Epidemiology Team, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Frimat","sequence":"additional","affiliation":[{"name":"Nephrology department, University Regional Hospital, University of Lorraine, Nancy, Grand Est, France"},{"name":"EA 4360, INSERM CIC-EC, Apemac, University of Lorraine, Nancy, Grand Est, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Combe","sequence":"additional","affiliation":[{"name":"Bordeaux University, INSERM, Bordeaux Public Health, U1219, CIC 1401, Bordeaux, France"},{"name":"Centre Hospitalier d\u2019Ard\u00e8che M\u00e9ridionale, Aubenas, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Fouque","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Nutrition, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-B\u00e9nite, France"},{"name":"Carmen, University Claude Bernard Lyon 1, INSERM U1060, Pierre Benite, Auvergne-Rh\u00f4ne-Alpes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Laville","sequence":"additional","affiliation":[{"name":"Carmen, University Claude Bernard Lyon 1, INSERM U1060, Pierre Benite, Auvergne-Rh\u00f4ne-Alpes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jacquelinet","sequence":"additional","affiliation":[{"name":"Centre for Research in Epidemiology and Population Health (CESP), Paris-Saclay University, Inserm U1018, Versailles Saint-Quentin University, Clinical Epidemiology Team, Villejuif, France"},{"name":"Medical and Scientific Department, Agence de la biomedecine, La Plaine Saint-Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves-Edouard","family":"Herpe","sequence":"additional","affiliation":[{"name":"Biobanque de Picardie, Biological Resource Center of the Amiens University Hospital, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Montalescot","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, Laboratoire de Psychopathologie et Processus de Sant\u00e9, Boulogne-Billancourt, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam Amine","family":"Larabi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Raymond Poincar\u00e9 Hospital, AP-HP, Garches, France"},{"name":"UVSQ, Universit\u00e9 Paris-Saclay, Inserm U1018, CESP, \u00c9quipe MOODS, MasSpecLab, Montigny-le-Bretonneux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Alencar de Pinho","sequence":"additional","affiliation":[{"name":"Centre for Research in Epidemiology and Population Health (CESP), Paris-Saclay University, Inserm U1018, Versailles Saint-Quentin University, Clinical Epidemiology Team, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A","family":"Massy","sequence":"additional","affiliation":[{"name":"Centre for Research in Epidemiology and Population Health (CESP), Paris-Saclay University, Inserm U1018, Versailles Saint-Quentin University, Clinical Epidemiology Team, Villejuif, France"},{"name":"AP-HP, University Hospital Group Pais Saclay, Ambroise Par\u00e9 Hospital, University Medical Department 4; Nephrology Department, Boulogne-Billancourt, \u00cele-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Raymond Poincar\u00e9 Hospital, AP-HP, Garches, France"},{"name":"UVSQ, Universit\u00e9 Paris-Saclay, Inserm U1018, CESP, \u00c9quipe MOODS, MasSpecLab, Montigny-le-Bretonneux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3064-2480","authenticated-orcid":false,"given":"Marion","family":"P\u00e9pin","sequence":"additional","affiliation":[{"name":"Ambroise Par\u00e9 Hospital, University Medical Department 1, Geriatric Department, AP-HP, University Hospital Group Pais Saclay, Versailles Saint-Quentin University, Boulogne-Billancourt, France"},{"name":"Centre for Research in Epidemiology and Population Health (CESP), Paris-Saclay University, Inserm U1018, Versailles Saint-Quentin University, Clinical Epidemiology Team, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"2026091806103359000_29.1.e302537.1","unstructured":"Depressive disorder (depression). Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression [Accessed 22 Oct 2025]."},{"key":"2026091806103359000_29.1.e302537.2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21873-2","article-title":"Prevelance of depression and anxiety with their effect on quality of life in chronic kidney disease patients","volume":"12","author":"Alshelleh","year":"2022","journal-title":"Sci Rep"},{"key":"2026091806103359000_29.1.e302537.3","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100790","article-title":"Depressive Symptoms, Antidepressants, and Clinical Outcomes in Chronic Kidney Disease: Findings from the CRIC Study","volume":"6","author":"Hernandez","year":"2024","journal-title":"Kidney Med"},{"key":"2026091806103359000_29.1.e302537.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2020.06.002"},{"key":"2026091806103359000_29.1.e302537.5","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2015.5"},{"key":"2026091806103359000_29.1.e302537.6","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02660221"},{"key":"2026091806103359000_29.1.e302537.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-018-0018-2"},{"key":"2026091806103359000_29.1.e302537.8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-334634"},{"key":"2026091806103359000_29.1.e302537.9","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1038\/s41467-024-47273-w","article-title":"Immunoregulatory role of the gut microbiota in inflammatory depression","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"key":"2026091806103359000_29.1.e302537.10","doi-asserted-by":"crossref","first-page":"115467","DOI":"10.1016\/j.bbr.2025.115467","article-title":"Depression in chronic kidney disease: Particularities, specific mechanisms and therapeutic considerations, a narrative review","volume":"483","author":"Lefr\u00e8re","year":"2025","journal-title":"Behav Brain Res"},{"key":"2026091806103359000_29.1.e302537.11","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.18632\/aging.202523","article-title":"Indoxyl sulfate caused behavioral abnormality and neurodegeneration in mice with unilateral nephrectomy","volume":"13","author":"Sun","year":"2021","journal-title":"Aging (Milano)"},{"key":"2026091806103359000_29.1.e302537.12","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1016\/j.ekir.2024.07.021","article-title":"Increased Blood-Brain Barrier Permeability and Cognitive Impairment in Patients With ESKD","volume":"9","author":"Bobot","year":"2024","journal-title":"Kidney Int Rep"},{"key":"2026091806103359000_29.1.e302537.13","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-022-02990-5"},{"key":"2026091806103359000_29.1.e302537.14","doi-asserted-by":"crossref","first-page":"6687","DOI":"10.3390\/ijms21186687","article-title":"p-Cresol Sulfate Caused Behavior Disorders and Neurodegeneration in Mice with Unilateral Nephrectomy Involving Oxidative Stress and Neuroinflammation","volume":"21","author":"Sun","year":"2020","journal-title":"IJMS"},{"key":"2026091806103359000_29.1.e302537.15","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1016\/j.ekir.2025.05.037","article-title":"Association of Phenylacetylglutamine and Cognitive Impairment in CKD","volume":"10","author":"Levassort","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026091806103359000_29.1.e302537.16","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft388"},{"key":"2026091806103359000_29.1.e302537.17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cca.2020.04.032","article-title":"Quantification of free and protein bound uremic toxins in human serum by LC-MS\/MS: Comparison of rapid equilibrium dialysis and ultrafiltration","volume":"507","author":"Fabresse","year":"2020","journal-title":"Clin Chim Acta"},{"key":"2026091806103359000_29.1.e302537.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2021.114037"},{"key":"2026091806103359000_29.1.e302537.19","doi-asserted-by":"crossref","first-page":"2050312113514576","DOI":"10.1177\/2050312113514576","article-title":"Performance of the 10-item Center for Epidemiologic Studies Depression scale for caregiving research","volume":"1","author":"Andresen","year":"2013","journal-title":"SAGE Open Med"},{"key":"2026091806103359000_29.1.e302537.20","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000308"},{"key":"2026091806103359000_29.1.e302537.21","doi-asserted-by":"crossref","first-page":"107794","DOI":"10.1016\/j.phrs.2025.107794","article-title":"Gut microbiota-derived metabolite phenylacetylglutamine in cardiovascular and metabolic diseases","volume":"217","author":"Chen","year":"2025","journal-title":"Pharmacol Res"},{"key":"2026091806103359000_29.1.e302537.22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/21691401.2025.2531752","article-title":"Revealing the impact of gut microbiota-derived metabolites on depression through network pharmacology","volume":"53","author":"Su","year":"2025","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"2026091806103359000_29.1.e302537.23","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019070728"},{"key":"2026091806103359000_29.1.e302537.24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99845-1","article-title":"Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature","volume":"11","author":"Brydges","year":"2021","journal-title":"Sci Rep"},{"key":"2026091806103359000_29.1.e302537.25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11357-020-00257-2","article-title":"The gut microbiome-derived metabolite trimethylamine N-oxide modulates neuroinflammation and cognitive function with aging","volume":"43","author":"Brunt","year":"2021","journal-title":"Geroscience"},{"key":"2026091806103359000_29.1.e302537.26","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2022.987697","article-title":"Tryptophan metabolites in depression: Modulation by gut microbiota","volume":"16","author":"Luki\u0107","year":"2022","journal-title":"Front Behav Neurosci"},{"key":"2026091806103359000_29.1.e302537.27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158493","article-title":"Tryptophan Metabolism in Depression: A Narrative Review with a Focus on Serotonin and Kynurenine Pathways","volume":"23","author":"Correia","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026091806103359000_29.1.e302537.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2015.05.053"},{"key":"2026091806103359000_29.1.e302537.29","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2341449","article-title":"Sweet, bloody consumption - what we eat and how it affects vascular ageing, the BBB and kidney health in CKD","volume":"16","author":"Schwarz","year":"2024","journal-title":"Gut Microbes"},{"key":"2026091806103359000_29.1.e302537.30","unstructured":"Center for epidemiologic studies depression scale - shortened version.pdf. Available: https:\/\/alswh.org.au\/wp-content\/uploads\/2020\/08\/DDSSection2.7CESD.pdf [Accessed 17 Apr 2025]."}],"container-title":["BMJ Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjment-2026-302537","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:11:14Z","timestamp":1789737074000},"score":1,"resource":{"primary":{"URL":"https:\/\/mentalhealth.bmj.com\/lookup\/doi\/10.1136\/bmjment-2026-302537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6,24]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/bmjment-2026-302537"],"URL":"https:\/\/doi.org\/10.1136\/bmjment-2026-302537","relation":{},"ISSN":["2755-9734"],"issn-type":[{"value":"2755-9734","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}